What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Immune system
Immunology, Internal medicine, Autoantibody, Fibrosis and Connective tissue disease are his primary areas of study.
In general Immunology, his work in Autoimmune disease, CD19, Lupus erythematosus and Immune system is often linked to Peripheral blood mononuclear cell linking many areas of study.
His research integrates issues of Gastroenterology and Endocrinology in his study of Internal medicine.
His Autoantibody research includes themes of Systemic scleroderma, Autoimmunity, Antigen and Single-nucleotide polymorphism.
His Fibrosis research is multidisciplinary, incorporating perspectives in CTGF, Connective tissue, Cytokine and Bleomycin.
His Connective tissue disease research is multidisciplinary, relying on both Systemic disease and Scleroderma.
His most cited work include:
- Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. (264 citations)
- Quantitative Genetic Variation in CD19 Expression Correlates with Autoimmunity (262 citations)
- Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy (229 citations)
What are the main themes of his work throughout his whole career to date?
Minoru Hasegawa mostly deals with Immunology, Internal medicine, Pathology, Connective tissue disease and Fibrosis.
His Immunology study often links to related topics such as Dermatomyositis.
His Internal medicine study combines topics in areas such as Gastroenterology and Endocrinology.
His study in Connective tissue disease is interdisciplinary in nature, drawing from both Scleroderma, Systemic disease, Immunopathology and Pulmonary fibrosis, Lung.
The Fibrosis study combines topics in areas such as Cancer research, Growth factor and Bleomycin.
As part of the same scientific family, he usually focuses on Autoantibody, concentrating on B cell and intersecting with CD19.
He most often published in these fields:
- Immunology (40.22%)
- Internal medicine (27.55%)
- Pathology (20.66%)
What were the highlights of his more recent work (between 2015-2021)?
- Dermatology (9.64%)
- Immunology (40.22%)
- Fibrosis (15.70%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Dermatology, Immunology, Fibrosis, Pathology and Cancer research.
He interconnects Internal medicine and Linkage disequilibrium in the investigation of issues within Immunology.
His Internal medicine study incorporates themes from Erythema induratum and Oncology.
The various areas that Minoru Hasegawa examines in his Fibrosis study include Biomarker, Transforming growth factor, Autoimmune disease and Growth factor.
His biological study spans a wide range of topics, including In vivo, Antibody and Antigen.
His research investigates the link between Immune system and topics such as B cell that cross with problems in Autoantibody.
Between 2015 and 2021, his most popular works were:
- Antimelanoma differentiation‐associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis (67 citations)
- Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity (50 citations)
- Oropharyngeal Dysphagia in Dermatomyositis: Associations with Clinical and Laboratory Features Including Autoantibodies. (42 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Immune system
His primary scientific interests are in Immunology, Dermatology, Pharmacology, Internal medicine and Wound burn.
His Immunology research incorporates elements of Fibrosis, Linkage disequilibrium and CD80.
His research in Dermatology intersects with topics in Pain management, Patient positioning, Rheumatoid arthritis and Pathology.
His studies deal with areas such as Endocrinology and Oncology as well as Internal medicine.
His Autoantibody study combines topics from a wide range of disciplines, such as Scleroderma, Immune system and B cell, Regulatory B cells.
Minoru Hasegawa has researched Scleroderma in several fields, including Autoimmune disease and B-cell activating factor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
